Tempus AI, Inc. Class A TEM 深 沪
等待开盘 06-26 09:30:00 美东时间
54.88
+2.940
+5.66%
华盛通- 最 高55.65
- 今 开52.59
- 成交量 867.10万股
- 最 低 46.68
- 昨 收 51.94
- 总市值 0
- 52周最高 103.42
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 41.73
- 委 比 -71.07%
- 总股本 --
- 历史最高 103.42
- 量 比 1.57
- 振 幅 17.27%
- 历史最低 22.89
- 每 手 1
- 风险率 14.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Ambry Study Shows RNA Testing May Clarify Uncertain Genetic Results
Ambry Genetics, a leader in clinical genomic testing, and a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ:TEM), announced peer-reviewed research demonstrating the potential for variant-specific RNA testing to
06-09 18:07
Sanofi-Owkin Expand AI Collaboration With New Agentic AI Initiative
Owkin and Sanofi expand their AI partnership with a five-year deal to develop agentic systems aimed at accelerating drug research.
06-05 19:01
BTIG Reiterates Buy on Tempus AI, Maintains $80 Price Target
BTIG analyst Mark Massaro reiterates Tempus AI (NASDAQ:TEM) with a Buy and maintains $80 price target.
06-01 18:33
Consumer Tech News (May 25-29): Dell, IBM, CrowdStrike, Meta Lead Big Tech AI Push
Dell beats massive estimates, IBM launches $5B Project Lightwell, CrowdStrike expands cyber insurance AI efforts, and Meta adds paid AI subscriptions across platforms.
05-31 21:53
Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery
Bristol Myers Squibb expands AI efforts through Anthropic and Tempus partnerships as shares edge higher Wednesday.
05-21 01:09
Gilead Expands Tempus AI Partnership To Boost Oncology Pipeline
Gilead expands Tempus AI deal and licenses Kymera's KT-200, advancing oncology pipeline with data, analytics and drug development.
04-10 01:14
Tempus AI Stock Jumps, ALERT Trial Results Boost EHR Automation Buzz
Tempus AI says ALERT trial shows higher valve procedures and faster care, while analysts keep a Buy rating with varied price targets.
04-01 22:23
Chasing Emerging Markets Growth: T. Rowe Price Unveils New Active ETF
T. Rowe Price launches the Emerging Markets Equity Research ETF (TEMR), an actively managed fund targeting long-term growth across emerging markets stocks.
03-13 02:30
AI-Powered Tempus Inks New Multi-Year Merck Deal
Tempus AI expands its Merck deal as markets slide. Analysts stay bullish, but the stock trades near 52-week lows.
03-04 03:33
Consumer Tech News (Feb 23-27): US–Taiwan Trade Tensions Escalates, Amazon Invests $12B In US & More
Mark Kelly emphasized the rapid workplace impact of artificial intelligence and called for "practical rules" that protect families while preserving innovation. U.S.–Taiwan trade tensions escalated after the Supreme Court struck down former President Donald Trump's emergency tariff authority. Trump responded by criticizing Taiwan's semiconductor dominance and proposing new tariffs.
03-01 21:00
